Lim H H, Ho K M, Choi W Y, Teoh G S, Chiu K Y
Department of Anaesthesia and Intensive Care, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
Anesth Analg. 2000 Nov;91(5):1203-6. doi: 10.1097/00000539-200011000-00029.
We investigated the efficacy of IV atropine for preventing spinal anesthesia-induced hypotension in elderly patients. Seventy-five patients undergoing transurethral prostate or bladder surgery were randomized to receive either placebo (n = 25), atropine 5 microg/kg (small-dose atropine, n = 25) or atropine 10 microg/kg (large-dose atropine, n = 25) after the induction of spinal anesthesia. All the patients received an IV infusion of 10 mL/kg 0.9% normal saline over 10 min before the induction of anesthesia. The systolic blood pressure decreased in all three groups after spinal anesthesia. There was a significant increase in the mean heart rate in both atropine groups as compared to the placebo group (placebo group: 78 bpm, 95% confidence interval [CI]: 76.6-78.5; small-dose atropine group: 86 bpm, 95% CI 83.9-88.8; large-dose atropine group: 97 bpm, 95% CI 94.5-100.3; P: = 0.001). There was a significant decrease in the incidence of hypotension in patients who received atropine (placebo group: 76%, small-dose atropine group: 52%, large-dose atropine group: 40%, P: = 0.03). The mean dose of ephedrine required was significantly decreased in the atropine groups (placebo group: 12.2 mg [SD= 10.5], small-dose atropine group: 7.4 mg [SD= 10.0], large-dose atropine group: 5.4 mg [SD= 8.7 mg], P: = 0.048). The total amount of IV fluid and number of patients requiring metaraminol in addition to 30 mg of ephedrine were not significantly different among the three groups. Significant side effects, such as confusion, ST segment changes or angina were not detected in any of the patients. We conclude that IV atropine may be a useful supplement to the existing methods in preventing hypotension induced by spinal anesthesia.
IV atropine increases heart rate in a dose-dependent manner in elderly patients undergoing spinal anesthesia. It reduces the incidence of hypotension and the dose of ephedrine required. Small-dose atropine may be a useful supplement in preventing spinal anesthesia-induced hypotension in elderly patients.
我们研究了静脉注射阿托品预防老年患者脊髓麻醉所致低血压的疗效。75例接受经尿道前列腺或膀胱手术的患者在脊髓麻醉诱导后被随机分为三组,分别接受安慰剂(n = 25)、5μg/kg阿托品(小剂量阿托品组,n = 25)或10μg/kg阿托品(大剂量阿托品组,n = 25)。所有患者在麻醉诱导前10分钟内静脉输注10 mL/kg的0.9%生理盐水。脊髓麻醉后三组患者的收缩压均下降。与安慰剂组相比,阿托品组患者的平均心率显著增加(安慰剂组:78次/分钟,95%置信区间[CI]:76.6 - 78.5;小剂量阿托品组:86次/分钟,95% CI 83.9 - 88.8;大剂量阿托品组:97次/分钟,95% CI 94.5 - 100.3;P = 0.001)。接受阿托品治疗的患者低血压发生率显著降低(安慰剂组:76%,小剂量阿托品组:52%,大剂量阿托品组:40%,P = 0.03)。阿托品组所需麻黄碱的平均剂量显著降低(安慰剂组:12.2 mg [标准差= 10.5],小剂量阿托品组:7.4 mg [标准差= 10.0],大剂量阿托品组:5.4 mg [标准差= 8.7 mg],P = 0.048)。三组患者的静脉输液总量以及除30 mg麻黄碱外还需要间羟胺的患者数量无显著差异。未在任何患者中检测到明显的副作用,如意识模糊、ST段改变或心绞痛。我们得出结论,静脉注射阿托品可能是预防脊髓麻醉所致低血压的现有方法的有益补充。
在接受脊髓麻醉的老年患者中,静脉注射阿托品可使心率呈剂量依赖性增加。它可降低低血压发生率和所需麻黄碱的剂量。小剂量阿托品可能是预防老年患者脊髓麻醉所致低血压的有益补充。